# Dynamic Measures of Neurochemistry in Mood Disorders

> **NCT00178828** · PHASE4 · COMPLETED · sponsor: **Vanderbilt University Medical Center** · enrollment: 42 (actual)

## Conditions studied

- Depression

## Interventions

- **DRUG:** sertraline
- **DRUG:** bupropion

## Key facts

- **NCT ID:** NCT00178828
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-10
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2017-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00178828

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00178828, "Dynamic Measures of Neurochemistry in Mood Disorders". Retrieved via AI Analytics 2026-08-22 from https://api.ai-analytics.org/clinical/NCT00178828. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*